Linc

Linc Equity Ratio

The Equity Ratio of Linc (LINC.ST) as of Nov 20, 2026 is 99.74 %. In the previous year, Equity Ratio was 99.82 % — a change of -0.08% (lower).

Equity Ratio

99.74 %

YoY

-0.08%

Last updated:

Equity Ratio of Linc is 2025 99.74 % . Equity Ratio of Linc was 2024 99.82 % . It decreases by -0.08% lower compared to the previous year.

The Linc Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2018
99.80 SEK
Jan 1, 2019
99.69 SEK
Jan 1, 2020
94.54 SEK
Jan 1, 2021
96.53 SEK
Jan 1, 2022
99.90 SEK
Jan 1, 2023
99.92 SEK
Jan 1, 2024
99.82 SEK
Jan 1, 2025
99.74 SEK
The Linc Equity Ratio history
YEAREquity RatioYoY
99.74 %-0.08%
99.82 %-0.10%
99.92 %+0.02%
99.90 %+3.49%
96.53 %+2.11%
94.54 %-5.17%
99.69 %-0.11%
99.80 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Linc Stock analysis

What does Linc do? Linc AB generates revenue through long-term share ownership in Nordic life science companies, focusing on pharmaceutical and medical technology sectors. The company invests in both private and public firms, including early-stage drug development and operational medical technology companies. Linc Invest actively supports portfolio companies by collaborating with management, founders, and boards to unlock growth potential and drive expansion. Its industrial network enables strategic participation in nomination committees and development planning. The firm targets Nordic life science product-oriented companies, prioritizing pharmaceuticals and medical technology. Investments span research and operational phases, with drug development typically occurring earlier than in medical technology. Linc AB maintains a hands-on approach as a long-term owner, leveraging its network to assist portfolio companies in achieving ambitious development goals. Linc AB's business model centers on active ownership and strategic partnerships within the Nordic life science ecosystem. It focuses on companies with strong product pipelines, particularly in pharmaceuticals, where investments often occur during initial development stages. The company's role as a supportive shareholder drives value creation through collaborative governance and targeted expansion strategies. Linc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Linc stock

Equity Ratio of Linc is 99.74 % in 2025.

Equity Ratio of Linc changed from 99.82 % to 99.74 %, representing a -0.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio Linc since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's Linc with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Linc

All Key Metrics — Linc